Test Price
2,800 AED✅ Home Collection Available
ABCC9 Gene Dilated Cardiomyopathy Type 1O Genetic Test UAE | 2,800 AED
DHA CertifiedExecutive Summary & Core Metrics
High‑resolution next‑generation sequencing (NGS) for the detection of pathogenic variants in the ABCC9 gene, associated with dilated cardiomyopathy type 1O. This test offers definitive genetic diagnosis for at‑risk individuals and families in the UAE.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post‑test result interpretation by a DHA‑licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ABCC9 gene‑specific NGS test sequences all coding exons and flanking intronic regions at a depth exceeding 100×. This targeted approach identifies pathogenic, likely pathogenic, and variants of uncertain significance (VUS) linked to dilated cardiomyopathy type 1O, enabling accurate carrier screening and risk stratification for family members.
| Feature | Our Test (ABCC9 NGS) | Closest Alternative (Generic Cardiac Panel) |
|---|---|---|
| Precision | Single‑gene depth > 100×; full exon coverage | Multi‑gene, lower per‑gene coverage |
| Method | Targeted NGS + bioinformatic ACMG 2024 interpretation | Standard targeted sequencing |
| Turnaround | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocols
“A genetic diagnosis of dilated cardiomyopathy provides critical information for family screening and early intervention. However, interpretation requires integration with clinical data and family history. I recommend discussing all results with a cardiologist and genetic counsellor to guide management.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Clinical Advisory: Medication Use
⚠️ Medication Warning
Do not discontinue any prescribed cardiovascular medication without consulting your treating physician. Genetic results are supplementary, not a substitute for ongoing clinical care.
Exclusion Criteria & Emergency Red Flags
The following conditions preclude this test or require immediate medical attention:
- Patients in acute cardiac decompensation or unstable arrhythmia.
- Individuals under 18 years old without valid informed consent from a legal guardian (pursuant to Federal Decree‑Law No. 4 of 2016 on Medical Liability).
- Pregnant women, due to potential incidental findings impacting reproductive decisions.
- Inability to provide valid informed consent in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
🚨 If you experience severe chest pain, fainting (syncope), or acute shortness of breath, seek emergency medical attention immediately. This test is not a replacement for acute diagnostic workup.
Patient FAQ & Clinical Guidance
1. What is the ABCC9 gene dilated cardiomyopathy test?
This NGS‑based analysis sequences the entire ABCC9 gene to identify pathogenic variants that cause dilated cardiomyopathy type 1O. It clarifies carrier status and genetic risk for at‑risk family members.
2. How long does it take to receive results?
Turnaround time is 3 to 4 weeks due to high‑depth sequencing, multiple quality checks, and clinical interpretation by a DHA‑certified Consultant Medical Geneticist.
3. Is home blood collection available in the UAE?
Yes, ISO‑certified cold‑chain home phlebotomy is available daily from 8 AM to 11 PM, performed by DHA‑licensed phlebotomists using VIP mobile units. This service ensures sample integrity from collection to laboratory processing.
UAE Regulatory & Data Privacy Adherence
Your medical data is protected under the following UAE federal laws:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governs the collection, processing, and storage of personal health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – establishes security standards for health data and electronic medical records.
All genetic results are handled with strict confidentiality and are only released to the ordering physician and the patient upon verified consent. DNA Labs UAE is fully compliant with these frameworks.
Clinical & Logistical Metadata
| Test Name | ABCC9 Gene Dilated Cardiomyopathy Type 1O Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole blood (peripheral) – collected via VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection |
| Methodology Used | Targeted NGS, full gene sequencing > 100× depth, ACMG 2024 variant classification |
| ICD-10-CM Code | I42.0 |
| LOINC Code | 81326-5 |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians